John Eisman ANZBMS-MEPSA-ANZORS 2022

Abstracts this author is presenting:

• Fracture risk in women with osteoporosis treated with gastro-resistant (ec) risedronate versus immediate release risedronate or alendronate: a claims data analysis in the United States — ANZBMS/AMGEN Outstanding Abstracts